Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.

To see complete record on, please visit this link

Id: NCT00979693

Organisation Name: Multidisciplinary Association for Psychedelic Studies

Overal Status: Withdrawn

Start Date: January 2012

Last Update: June 16, 2022

Lead Sponsor: Multidisciplinary Association for Psychedelic Studies

Brief Summary: This study is to find out about whether two sessions of psilocybin-assisted psychotherapy are safe and will help people who are anxious as a result of having stage IV melanoma and will involve two sessions of psychotherapy combined with either 4 or 25 mg psilocybin. The study will measure anxiety, depression, quality of life and spirituality before and after psilocybin-assisted psychotherapy, natural killer cells (a type of immune cell) will be counted from blood samples taken the day after psilocybin-assisted psychotherapy, and people will keep daily diaries reporting on how anxious they feel for each day in the study.

  • Anxiety
  • Stage IV Melanoma

Total execution time in seconds: 0.18599104881287